AAVLP-HPV + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Papillomavirus Infections
Conditions
Papillomavirus Infections
Trial Timeline
Feb 28, 2019 → May 29, 2020
NCT ID
NCT03929172About AAVLP-HPV + Placebo
AAVLP-HPV + Placebo is a phase 1 stage product being developed by 2A Pharma for Papillomavirus Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT03929172. Target conditions include Papillomavirus Infections.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03929172 | Phase 1 | Completed |
Competing Products
20 competing products in Papillomavirus Infections